These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24228409)

  • 21. [Targetting therapy of leakaemia stem cells].
    Yang CZ
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1372-4. PubMed ID: 17785053
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.
    Misaghian N; Ligresti G; Steelman LS; Bertrand FE; Bäsecke J; Libra M; Nicoletti F; Stivala F; Milella M; Tafuri A; Cervello M; Martelli AM; McCubrey JA
    Leukemia; 2009 Jan; 23(1):25-42. PubMed ID: 18800146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular targeted therapy for leukemic stem cells].
    Kikushige Y
    Nihon Rinsho; 2015 May; 73(5):811-5. PubMed ID: 25985636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Leukemic stem cell targeting therapy].
    Chen YX; Zhong XY
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):401-3. PubMed ID: 17152481
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence that high-migration drug-surviving MOLT4 leukemia cells exhibit cancer stem cell-like properties.
    Huang X; Xiong M; Jin Y; Deng C; Xu H; An C; Hao L; Yang X; Deng X; Tu Z; Li X; Xiao R; Zhang Q
    Int J Oncol; 2016 Jul; 49(1):343-51. PubMed ID: 27210806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GLI2 inhibition abrogates human leukemia stem cell dormancy.
    Sadarangani A; Pineda G; Lennon KM; Chun HJ; Shih A; Schairer AE; Court AC; Goff DJ; Prashad SL; Geron I; Wall R; McPherson JD; Moore RA; Pu M; Bao L; Jackson-Fisher A; Munchhof M; VanArsdale T; Reya T; Morris SR; Minden MD; Messer K; Mikkola HK; Marra MA; Hudson TJ; Jamieson CH
    J Transl Med; 2015 Mar; 13():98. PubMed ID: 25889765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.
    Camacho V; McClearn V; Patel S; Welner RS
    Int J Hematol; 2017 May; 105(5):566-577. PubMed ID: 28176225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow neoplastic niche in leukemia.
    Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
    Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral regulation of human leukemic progenitor cell cycle: the case for turning off the cell cycle.
    Park CH
    J Lab Clin Med; 1987 May; 109(5):571-4. PubMed ID: 3572205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction to the review series on leukemic stem cells.
    Löwenberg B
    Blood; 2017 Mar; 129(12):1567. PubMed ID: 28159739
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of mature leukemic cells in the amplification of leukemic stem cells in a murine model.
    Dührsen U; Knieling G; Hossfeld DK
    Int J Cancer; 1995 Mar; 60(5):652-9. PubMed ID: 7860140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 3. Molecular pathogenesis of leukemia].
    Kurokawa M
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2370-4. PubMed ID: 24228429
    [No Abstract]   [Full Text] [Related]  

  • 33. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; introduction].
    Kimura K; Nagai R
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2284. PubMed ID: 24228413
    [No Abstract]   [Full Text] [Related]  

  • 34. Leukemia stem cells.
    Testa U
    Ann Hematol; 2011 Mar; 90(3):245-71. PubMed ID: 21107841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecule regulation of normal and leukemic stem cells.
    Fares I; Rivest-Khan L; Cohen S; Sauvageau G
    Curr Opin Hematol; 2015 Jul; 22(4):309-16. PubMed ID: 26049751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 2) Clinical guidelines and consensus development].
    Fukui T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2301-6. PubMed ID: 24228417
    [No Abstract]   [Full Text] [Related]  

  • 37. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 4) Guidelines in Japan and in the world].
    Urashima M
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2313-8. PubMed ID: 24228419
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell Density-Dependent Cytological Stage Profile and Its Application for a Screen of Cytostatic Agents Active Toward Leukemic Stem Cells.
    Lica JJ; Grabe GJ; Heldt M; Misiak M; Bloch P; Serocki M; Switalska M; Wietrzyk J; Baginski M; Hellmann A; Borowski E; Skladanowski A
    Stem Cells Dev; 2018 Apr; 27(7):488-513. PubMed ID: 29431006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 3. Social impacts and controversial points of clinical practice guidelines; 3) Impact, evaluation and legal issues of clinical practice guidelines].
    Shimbo T
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2307-12. PubMed ID: 24228418
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.